The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages 216-219

  Cohen, Adam L ^a   Sarid, Rami ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Monoclonal gammopathies, benign; Paraproteinemias; Pulmonary embolism; Venous thrombosis

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; RISK ASSESSMENT; SERUM; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; HOSPITALS, VETERANS; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VENOUS THROMBOSIS;

EID: 76949094074     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.01.004     Document Type: Article

References (18)

1. Goldhaber S.Z. Pulmonary embolism. N Engl J Med 339 (1998) 93-104
2. Dismuke S.E., and Wagner E.H. Pulmonary embolism as a cause of death: The changing mortality in hospitalized patients. JAMA 255 (1986) 2039-2042
3. Shorr A.F. The pharmacoeconomics of deep vein thrombosis treatment. Am J Med 120 (2007) S35-41
4. Zangari M., Elice F., Fink L., and Tricot G. Thrombosis in multiple myeloma. Expert Rev Anticancer Ther 7 (2007) 307-315
5. Kristinsson S.Y., Fears T.R., Gridley G., Turesson I., Mellqvist U.H., Bjorkholm M., et al. Deep vein thrombosis following monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. Blood 112 (2008) 3582-3586
6. Palumbo A., Rajkumar S.J., Dimopoulos M.A., Richardson P.G., San Miguel J., Barlogie B., et al. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 22 (2008) 414-423
7. Srkalovic G., Cameron M.G., Rybicki L., Deitcher S.R., Kattke-Marchant K., and Hussein M.A. Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic Disease. Cancer 101 (2004) 558-566
8. Sallah S., Huasian A., Wan J., Vos P., and Nguyen N.P. The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance. Ann Oncol 15 (2004) 1490-1494
9. Righini M., Boehlen F., Gueddi S., Le Gal D., and de Moerloose P. Extensive thromboembolic event as initial presentation of monoclonal gammopathy of indetermined significance. Thromb Haemost 96 (2006) 93-94
10. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the international myeloma working group. Br J Haemotol 121 (2003) 749-757
11. Keren D.F. Coagulation disorders in patients with monoclonal gammopathies. Hematol Oncol Clin North Am 7 (1993) 1153-1159
12. Disdier P., Swiader L., Aillaud M., Boucraut J., Harlé J.R., and Weiller P.J. IgM monoclonal gammopathy, lymphoid proliferations, and lupus anticoagulant. Am J Med 102 (1997) 319-320
13. Gabriel D.A., Smith L.A., Folds J.D., Davis L., and Cancelosi S.E. The influence of immunoglobulin (IgG) on the assembly of fibrin gels. J Lab Clin Med 101 (1983) 545-552
14. Kauffmann R.H., Veltkamp J.J., Van Tilburg N.H., and Van ES L.A. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 65 (1978) 607-613
15. Wattanakit K., Cushman M., Stehman-Breen C., Heckbert S.R., and Folsom A.R. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19 1 (Jan 2008) 135-140
16. Northrup P.G., McMahon M.M., Ruhl A.P., Altschuler S.E., Volk-Bednarz A., Caldwell S.H., et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 101 (2006) 1524-1528
17. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., and Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111 (May 2008) 4902-4907
18. Kyle R.A., Therneau T.M., and Rajmukar S.V. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: The original Mayo Clinic series 25 tears later. Mayo Clin Proc 79 (2004) 859-866